Testosterone Base

供应商:

供应产品

Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states that approximately 5 million American men do not produce enough of the hormone testosterone. Axiron is a highly profitable testosterone replacement therapy, with a patent expiration of February 19, 2017. The testosterone replacement Axiron generated over $48 million dollars in profit in 2011.

Coined “The Wittert Study”, after Gary Wittert who is the leader of this study, this novel study is banking on being the first of many to address the worldwide epidemic of type 2 diabetes using testosterone treatment as a preventative. The International Diabetes Federation has stated that the cost to treat type 2 diabetes worldwide now hovers at 471 billion dollars.



在线询价

至:
Your E-mail:
消息正文:


Send to other suppliers

Other supplier products

Testosterone Base Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states tha...
Testosterone Enanthate Usage: Pharmaceutical material, Steroid hormone, Anabolin. Clinically for the treatment of male sexual function decline, aplastic anemia and other ...
Testosterone Decanoate (Steroids) 1, High quality with competitive price: 1)Standard: Enterprise Standard 2)All Purity¡Ý99% 3)We are manufacturer and can provide high q...
Testosterone Sustanon (Steroids) Testosterone Sustanon used Pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones. Is a new type of hormonal p...
Testosterone Base Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states tha...
供应产品

Same products

1232 卖方: VseParki
1232 卖方: VseParki
卖方: Yiwu Shining Crystal Import and Export Co.,ltd
卖方: Yiwu Shining Crystal Import and Export Co.,ltd
Capillary Wormwood Extract
Capillary Wormwood Extract 卖方: Wuhan Yuancheng Group